Officer Dennis Mulroy Files to Sell Additional $1.03M in Stock
ANAB has more than doubled off its 52-week low of $11.402.
Summary
AnaptysBio officer Dennis Mulroy has filed to sell an additional $1.03 million in company stock, continuing a recent trend of significant insider selling.
Key Events · Ownership and Investor Activity · ANAB
-
Officer Files Intent to Sell
Dennis Mulroy, an officer, filed a Form 144 to sell 20,000 shares of common stock, valued at approximately $1.03 million.
-
Continuation of Insider Selling
This filing extends a pattern of significant insider selling by Mulroy, who has sold or filed to sell over $12 million in shares in the last three months.
-
Context of Corporate Actions
The ongoing insider selling follows the company's recent biopharma spin-off and the announcement of a $100 million share repurchase program.
Analysis · ANAB · Life Sciences
This Form 144 indicates Officer Dennis Mulroy's intent to sell an additional $1.03 million worth of common stock. This is part of a consistent pattern of insider selling by Mulroy, who has filed to sell over $12 million in shares in the last three months. This ongoing distribution by a key officer, following the company's recent spin-off and the announcement of a $100 million share repurchase program, could raise questions about management's long-term conviction despite the company's efforts to return capital to shareholders.
At the time of this filing, ANAB was trading at $51.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.